PLoS ONE (Jan 2021)

Perceived barriers to Chagas disease screening among a diverse group of prenatal care providers.

  • Helen Mahoney West,
  • Carly E Milliren,
  • Olivera Vragovic,
  • Julia R Köhler,
  • Christina Yarrington

DOI
https://doi.org/10.1371/journal.pone.0246783
Journal volume & issue
Vol. 16, no. 2
p. e0246783

Abstract

Read online

BackgroundChagas disease is a vector borne infection of poverty endemic to Latin America which affects an estimated 40,000 women of child-bearing age in the United States (US). In the US Chagas disease is concentrated among individuals who have lived in endemic areas. Prenatal diagnosis and treatment are needed to prevent congenital transmission. The objective of this study was to assess perceived barriers to Chagas disease screening among prenatal care providers in Obstetrics/Gynecology and Family Medicine Departments of a tertiary care safety-net hospital caring for a significant at-risk population.Methodology/principal findingsAn anonymous survey was distributed to 178 Obstetrics/Gynecology and Family Medicine practitioners. Of the 66 respondents, 39% thought Chagas screening was very important, and 48% somewhat important as a public health initiative. One third judged screening patients during clinic visits as very important. Most respondents (64%) reported being familiar with Chagas disease. However, only 32% knew how to order a test and only 22% reported knowing what to do if a test was positive.Conclusions/significanceThese findings will be incorporated into measures to facilitate full implementation of Chagas screening, and can inform initiatives at other centers who wish to address this deeply neglected infection among their patient families. Greater integration of information on Chagas disease screening and treatment in medical and nursing education curricula can contribute to addressing this disease with the focus that its potentially fatal sequelae merit.